A Multicenter, Prospective, Open-label, Non-randomized Single-arm Clinical Study of the Safety and Tissue Response to Photodynamic Therapy Using Porfimer Sodium for Injection as Treatment for Solid Lung Tumor Prior to Surgical Resection
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 09 Jan 2019
At a glance
- Drugs Porfimer sodium (Primary)
- Indications Lung cancer
- Focus Adverse reactions
- Sponsors Concordia International Corp.
- 03 Jan 2019 Planned End Date changed from 1 Mar 2019 to 1 Apr 2019.
- 03 Jan 2019 Planned primary completion date changed from 1 Jan 2019 to 1 Feb 2019.
- 05 Nov 2018 Planned End Date changed from 1 Feb 2019 to 1 Mar 2019.